Gabelli Funds LLC
- SEC CIK
- 0001081407
- Latest filing
- Aug 12, 2026
NAGE holding history
Niagen Bioscience, Inc. in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NAGE overviewAll 13F holders of NAGEFull Q2 2026 holdings
- Shares (Q2 2026)
- 247,500
- Value
- $789.5K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 247,500 | $789.5K | <0.1% | +32,815+15.3% | Added | Holders |
| Q1 2026 | 214,685 | $946.8K | <0.1% | +10,685+5.2% | Added | Holders |
| Q4 2025 | 204,000 | $1.30M | <0.1% | +16,500+8.8% | Added | Holders |
| Q3 2025 | 187,500 | $1.75M | <0.1% | −2,400−1.3% | Reduced | Holders |
| Q2 2025 | 189,900 | $2.74M | <0.1% | −14,900−7.3% | Reduced | Holders |
| Q1 2025 | 204,800 | $1.41M | <0.1% | +14,800+7.8% | Added | Holders |
| Q4 2024 | 190,000 | $1.01M | <0.1% | −10,000−5.0% | Reduced | Holders |
| Q3 2024 | 200,000 | $730.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 200,000 | $546.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 200,000 | $696.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 200,000 | $286.0K | <0.1% | +20,000+11.1% | Added | Holders |
| Q3 2023 | 180,000 | $262.8K | <0.1% | +15,000+9.1% | Added | Holders |
| Q2 2023 | 165,000 | $259.1K | <0.1% | +8,200+5.2% | Added | Holders |
| Q1 2023 | 156,800 | $239.9K | <0.1% | +104,800+201.5% | Added | Holders |
| Q4 2022 | 52,000 | $87.4K | <0.1% | +24,000+85.7% | Added | Holders |
| Q3 2022 | 28,000 | $34.0K | <0.1% | +28,000 | New | Holders |